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Abstract
Recent advances in biomedical research have resulted in the development of specific biomarkers for diagnostic testing of
disease condition or physiological risk. Of specific interest are aII-spectrin breakdown products (SBDPs), which are produced
by proteolytic events in traumatic brain injury and have been used as biomarkers to predict the severity of injury in humans
and other mammalian brain injury models. This study describes and demonstrates the successful use of antibody-based
mammalian SBDP biomarkers to detect head injury in migrating juvenile Chinook salmon (Oncorhynchus tshawytscha) that
have been injured during passage through high-energy hydraulic environments present in spillways under different
operational configurations. Mortality and injury assessment techniques currently measure only near-term direct mortality
and easily observable acute injury. Injury-based biomarkers may serve as a quantitative indicator of subacute physical injury
and recovery, and aid hydropower operators in evaluation of safest passage configuration and operation actions for
migrating juvenile salmonids. We describe a novel application of SBDP biomarkers for head injury for migrating salmon. To
our knowledge, this is the first documented cross-over use of a human molecular biomarker in a wildlife and operational risk
management scenario.
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Introduction
The migration of juvenile salmonids downriver on the
Columbia and Snake Rivers has been contested to be compro-
mised due to the multiple hydropower facilities located on these
rivers. Physical injury resulting from impacts with spillway
structures and turbines and hydraulic forces associated with spill
and sudden depth changes are two main hazards associated with
hydropower-related passage. Laboratory studies of the effect of
exposure to severe hydraulic events on juvenile salmonids have
found a variety of adverse effects caused by strike, shear, pressure
gradients, and disorientation. Recent studies have also found that
fish exposed to high shear and turbulence are subject to direct
injury and are more susceptible to predation than migrating fish
which have non-turbulent passage [1]. Current efforts to assess
these and strike-related injuries are performed using a direct injury
and mortality approach by gross observation up to 48 hours post
passage or condition treatment. Subacute injuries are not routinely
measured as there is no available metric to determine non-visible
injuries short of assessments for disorientation following laboratory
treatment, and this type of observation is not used in field studies
for testing hydropower structure configurations. Injury-based
biomarkers may serve as quantitative indicators of injury severity.
Because head injury likely results from physical trauma, such as
impacting a physical structure or extreme high velocities, the
development of a biomarker assay to quickly assess subacute
physical injury and recovery is essential to determine the impact of
hydropower structures on fish health.
Recent advances in biomedical research have resulted in the
development of a specific mammalian biomarker to rapidly assess
traumatic brain injury [2–6]. Breakdown products of the
cytoskeletal protein aII spectrin (280 kDa) are produced following
either calpain and/or caspase proteolysis; each digestion giving
rise to different sized spectrin breakdown products (SBDPs) [7–9].
Because rapid treatment following suspected traumatic brain
injury (TBI) is linked with survival and recovery, having a
biomarker that can be used as a diagnostic has great human health
importance [10].
Molecular biomarkers used in human health applications are often
applicable to other mammals; specifically for veterinary medicine
[11,12]. However, application for risk management of non-
mammalian wildlife has been limited or difficult due to the lack of
specific biomarkers for exposure and effect to environmental,
chemical, or physical stressors [13–16]. This study details the unique
application of a molecular biomarker for human brain injury in a
non-mammalian species for use in wildlife risk management.
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Fish collection
Chinook salmon juvenile fish (80–110 mm total length) used for
antibody cross-reactivity experiments were raised at the Pacific
Northwest National Laboratory Aquatics Research Facility in
Richland, WA, following transport from Lyons Ferry Hatchery
(Starbuck, WA) according to facility guidelines based US Fish and
Wildlife Service fish hatchery management practices, and in
accordance with approved animal care and use protocols. These
fish were used as a source of brain tissues for protease treatments
and were not subjected to any injury-inducing conditions, and are
referred to as hatchery control fish. Juvenile fish used in field
testing originated from a single cohort (110–140 mm total length)
from Lyons Ferry Hatchery and were maintained prior to and
after passage testing in 6 foot circular tanks with constant Snake
River water flow.
Field treatments and Tissue Dissection
Field treatments involved the use of balloon-tagged hatchery
fish into pipes constructed to release fish at predefined elevations
through various spillways as part of a US Army Corps of
Engineers contracted study at Ice Harbor Lock and Dam, WA, in
the spring of 2006. The study’s objective was to assess direct injury
and mortality as the result of passage under varying operating
conditions involving flow regimes [see 17, 18 for description of
similar studies]. Subsets of fish were collected from different
passage conditions according to facility guidelines based on US
Fish and Wildlife Service fish hatchery management practices, and
in accordance with approved animal care and use protocols. A
control group consisted of a subset of the fish obtained for the
study that were handled similarly to the passage treatments, but
were released through the juvenile fish bypass facility chute at Ice
Harbor Lock and Dam, and did not experience spillway passage
hydraulic conditions or deflector obstructions. The control group
in the field tests essentially served as a sham group to assess
impacts from spillway conditions and not from tagging and
handling conditions. Bypass chute conditions essentially consisted
of a horizontal raceway flume with a 2 foot drop from discharge to
collection. Fish were collected post-passage, examined for visible
external injury (eye hemorrhage, eye loss, descaling, and abrasions)
and sampled for brain tissue following the conclusion of the
standard 48-hour holding time for direct mortality (i.e., balloon-
tag) observations. Twenty fish each from different passage
scenarios and 10 control fish were collected and euthanized in
250 mg/L tricaine methane sulfonate followed by decapitation
prior to excising whole brain tissue. Brains were removed, placed
in individual cryotubes, and flash-frozen in liquid nitrogen.
Samples were stored at 280uC.
Salmon brain lysate preparation and protease treatment
The brain samples were pulverized with a small mortar and
pestle set over dry ice to a fine powder. The pulverized brain tissue
powder was then lysed for 90 min at 4uC with 50 mM Tris
(pH 7.4), 5 mM EDTA, 1% (v/v) Triton X-100, 1 mM DTT, 16
protease inhibitor cocktail (Roche Biochemicals). The brain lysates
were then centrifuged at 8,0006g for 5 min at 4uC to clear and
remove insoluble debris, snap-frozen and stored at 280uC until
used. Protein concentrations of tissue lysates were determined by
DC Protein assay (BioRad) with albumin standards. For in vitro
protease digestion, freshly prepared normal rat or hatchery control
salmon brain lysates (50 ug) were treated with purified proteases
(human porcine calpain-2 (Calbiochem) or recombinant human
caspase-3) with a substrate to protease ratio of 1/200 to 1/40 in a
buffer containing 50 mM HEPES (pH 7.4), 10 mM dithiothreitol,
1 mM EDTA (for caspase-3) or 2 mM excess CaCl2 (for calpain-2)
for 30–60 min at room temperature. For activating endogenous
proteases in salmon brain, freshly prepared normal salmon brain
lysate (50 ug) was incubated in a buffer containing 2 mM CaCl2,
50 mM HEPES (pH 7.4), 10 mM dithiothreitol, (for calpain
activation), or in a buffer containing 10 mM dATP, 10 mM
cytochrome C, 50 mM HEPES (pH 7.4), 10 mM dithiothreitol,
1 mM EDTA (for capase activation) for 2 h at room temperature.
SDS-polyacrylamide gel electrophoresis and
electrotransfer
Protein samples were prepared for sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) in two-fold
loading buffer containing 0.25 M Tris (pH 6.8), 0.2 M DTT,
8% SDS, 0.02% bromophenol blue, and 20% glycerol in distilled
H2O. Twenty micrograms (20 mg) of protein per lane were
resolved by SDS-PAGE on 6.5% Tris/glycine gels for 2 h at
200 V. Following electrophoresis, separated proteins were laterally
transferred to polyvinylidene fluoride (PVDF) membranes in a
transfer buffer containing 0.5 M glycine, 0.025 M Tris-HCl
(pH 8.3), and 10% methanol at a constant voltage of 20 V for
2 h at 4uC in a semi-dry transfer unit (Bio-Rad).
Immunoblotting and densitometry analysis
After electrotransfer, membranes were blocked for 1 h at
ambient temperature in 5% non-fat milk in TBS and 0.05%
Tween-2 (TBST), then incubated in primary antibody (aII-
spectrin monoclonal antibody, Affinity Res. Prod. Nottingham,
UK #FG6090 that is further biotinylated [8] or rabbit anti-
SBDP120 [19] in TBST with 5% milk at 1/1,000 to 1/3,000
dilution as recommended by the manufacturer) at 4uC overnight,
followed by four washes with TBST and a 2-hour incubation at
ambient temperature with either a secondary antibody linked to
horseradish peroxidase (enhanced chemiluminescence, (ECL)
method), or biotinylated secondary antibody (Amersham), fol-
lowed by a 30 min incubation with strepavidin-conjugated alkaline
phosphatase (colorimetric method). Colorimetric development was
performed with a one-step BCIP-NBT reagent (Sigma). Molecular
weights of intact proteins and their potential aII-spectrin
breakdown products (SBDPs) were assessed using rainbow colored
molecular weight standards (GE Health Tech.). Semi-quantitative
evaluation of protein and SBDP levels were evaluated via
computer-assisted densitometric scanning (Epson XL3500 high
resolution flatbed scanner) and image analysis with Image J
software (version 1.6) (NIH). Regression analyses were performed
using SigmaPlot 10.0 (Systat).
Results
Conservation of SBDPs in salmon brain
Whole salmon brain homogenates showed some similar SBDPs to
rat SBDPs when digested with calpain and caspase and detected via
Western blot with biotinylated anti-mammalian aII-spectrin (Fig. 1).
As controls, rat brain lysates (untreated or digested with human
calpain-2 or caspase-3) were also included. Calpain-digestion of rat
brain lysates produced the known SBDPs of 150 kDa and 145 kDa
(SBDP150, SBDP145), while capase-3 produced SBDPs of 150 kDa
and 120 kDa (SBDP150i, SBDP120) [7–9].
In the case of the salmon brain lysate, we observed some of the
same fragment sizes and some that were different. Digestion with
either exogenously added human caspase-3 or activation of the
endogenous salmon caspase with dATP and cytochrome C,
resulted in the production of a 110 kDa (SBDP110) not seen in the
Salmon Head Injury Biomarker
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120 kDa (SBDP120) in salmon brain lysate that is normally seen in
the rat. Both enzymes produced the 150 kDa (SBDP150) in the
fish brain. These observations suggest that aII-spectrin of salmon
contains several of the preferred cleavage sites for mammalian
caspase-3 to produce SBDP120 and SBDP150, but that it has
additional sites that are sensitive to both the mammalian and
endogenous caspase enzymes.
In the case of calpain, both the exogenously added enzyme and
the endogenous enzyme (activated by the addition of CaCl2)
produced a fragment of 150 kDa, as seen in the rat. But, both
enzymes also produced a SBDP of 110 kDa, which again was not
seen in the rat and did not produce the 145 kDa SBDP as seen in
the rat controls (Fig. 1). Regardless, the anti-mammalian aII-
spectrin monoclonal antibody was demonstrated to cross-react
with salmon aII-spectrin and its various SBDPs. Although a basal
level of SBDPs were observed in the control fish depicted in
Figure 1, intact aII-spectrin is the most abundant protein detected,
and is representative of the expression profile of a non-injured fish.
Amino acid alignment of a partial salmon predicted amino acid
sequence with two known fish protein sequences; zebrafish [20]
and fathead minnow, and the human protein sequence [21] show
conservation at the SBDP120 cleavage site, which was one of the
observed products following caspase cleavage (Fig. 2). The
cleavage site for calpain proteolysis (SBDP145) appears to be
conserved in both fathead minnow and zebrafish, but cannot be
confirmed for salmon, at the present time.
Field Testing
Ten control and twenty passage treatment fish were assessed for
expression of SBDPs using biotinylated anti-mammalian aII-
spectrin (Fig. 3A). Densitometric analyses of differentially
Figure 1. Endogenous and exogenous calpain and caspase-3 digestion of aII-spectrin in salmon brain lysate. Control Salmon brain was
either untreated, or incubated with dATP and cytochrome-C (to activate endogenous caspase) or with CaCl2 (to activate endogenous calpain) or
digested with exogenously added human calpain-2 or caspase-3. The masses of SBDP fragments or various molecular weight markers are as indicated
(Left panel). Fragments produced by calpain are indicated with red arrows (SBDP150 and SBDP110), while those produced by caspase are indicated
with blue arrows (SBDP150, SBDP120 and SBDP110). For comparison, rat brain lysate (control, or digested with calpain-2 (producing SBDP150 and
SBDP145) or caspase-3 (producing SBDP150i and SBDP120) was also included (right panel), as described before [8,27,28].
doi:10.1371/journal.pone.0004491.g001
Figure 2. aII-spectrin partial sequence alignment with human and fish counterparts. Reference amino acid number is given for human
sequence. Shown are regions pertinent to calpain proteolysis and caspase proteolysis with available salmon (CA049982), zebrafish (ZF, NP001091958),
fathead minnow (FHM, DT285007) and human aII-spectrin (AAB41498) amino acid sequences are compared.
doi:10.1371/journal.pone.0004491.g002
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fragments SBDP150, SBDP120 and SBDP110 are as indicated. Representative samples are shown. (B). Quantification of SBDP120 and SBDP110
elevation in injured salmon brain vs. controls. A total of n=10 for normal and n=20 for injured were quantified. Statistical significance (P,0.01,
Student T-test) for both SBDP120 and SBDP110 are indicated with **.
doi:10.1371/journal.pone.0004491.g003
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and passage treated groups with p,0.01 for SBDP120 and p,0.01
for SBDP110 (Fig. 3B). In both cases, the SBDP120 and
SBDP110 levels increased about 2-fold after salmon brain injury
(Figure 3B). We also note that there is a consistent basal level of
SBDPs even in control brain, representing turnover of aII-spectrin
in salmon brain tissues.
We further confirm that the SBDP120 observed is identical to
the SBDP120 observed in mammalian brain following brain injury
by showing that an antibody developed specifically to detect the
SBDP120 fragment in mammalian systems [19]. Using a subset of
8 samples per group (which was dictated by availability of brain
lysates), the SBDP120 fragment was detected in injured salmon
brain lysates (Fig. 4). The results further confirmed that there is a
statistically significant two-fold elevation (p,0.02) of caspase-
generated SBDP120 in the injured salmon brains (treatment
group) when compared to the control brain group (Fig. 4b). As for
SBDP110, at the present time, we cannot confirm whether it was
generated by endogenous calpain or caspase in salmon brain, since
both proteases appear to generate an SBDP of 110 kDa (see Fig. 2)
when chemically activated and no SBDP110 fragment-specific
antibody tools are available.
Numerical injury index scores (1–3) were given to injuries to
reflect injury severity with increasing physical trauma (abrasion/
descaling,eye hemorrhage,eye loss). When compared to observ-
able injuries, increasing expression of SBDP120 showed correla-
Figure 4. SBDP120-specific antibody confirming the presence of the SBDP120 fragment in injured salmon brain. Rabbit antibody
developed specifically to detect mammalian SBDP120 fragment [19] was used in Western blot analysis of salmon brain lysate for controls and injured
(treatment) salmon. (A) representative blot of salmon brain samples (4 controls and 4 injured) are shown. Positive and negative controls were rat
brain lysate digested with caspase-3 and calpain-2, respectively (right two lanes). (B) A total of n=8 from each group were used for densitometric
analysis of the SBDP120-specific band intensity, achieving statistical significance (**, P,0.02, Student T-test) between control and injured groups.
doi:10.1371/journal.pone.0004491.g004
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but expression was also seen above control level without obvious
injury (Fig. 5A,r
2=0.34). The pattern is less clear for increasing
expression of SBDP110 (Fig. 5B,r
2=0.01). A few of the treated
fish and one control fish that showed no visible injury had
relatively high levels of SBDP110 expression. With the exception
of a few treatment fish, most treatment fish had expression levels of
SBDP greater than 10.
Discussion
The routine application of molecular biomarkers in field
monitoring and testing has been limited to veterinary health.
However, increasing use of risk-surveillance approaches for
identification of health issues in livestock are being accepted for
both strategic and operational purposes [22]. While disease and
vector transmission implications to human health are the drivers for
this type ofriskmanagement,theanimal populationsinquestionare
monitored for disease exposure, overall health and productivity.
The extension of incorporating molecular markers for contami-
nant/disease exposure has been documented for assessing wild
populations of organisms at all trophic levels [16,23,24]. However,
the specificity of many of these markers, or biomarkers, remains
questionable for wildlife management practices [25,26]. Aside from
biological or chemical exposures, there has been no documented
assessment of acute or sub-lethal injury impacts resulting from
physical trauma in wildlife. The importance of this study illustrates
the success in using a biomarker for mammalian or human head
injury to determine head injury in migrating juvenile salmon as a
result of hydropower passage management; and represents the first
study to examine the efficacy of a human-based molecular
biomarker metric for risk management.
Unique and differential aII-spectrin breakdown products werefirst
shownto be generated by calpain and caspase proteasesincellculture
Figure 5. Correlation between SBDP expression with visible injury index. Open circles represent individual passage treatment fish (n=20),
while closed circles indicate individual control fish (n=10). Linear regression lines are depicted for each group. A. SBDP120 linear regression r
2=0.34.
B. SBDP110 linear regression r
2=0.01.
doi:10.1371/journal.pone.0004491.g005
Figure 6. Schematic for protease-mediated salmon brain injury and the production of SBDP biomarkers in the brain. For details, see
Discussion.
doi:10.1371/journal.pone.0004491.g006
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SBDP150i/SBDP120, respectively [27,28]. Pike and colleagues were
alsothefirsttoobservethesamemajorSBDPsindifferentaffectedrat
brain regions [9] and in the cerebrospinal fluid (CSF) compartment
[8] following experimental traumatic brain injury (controlled cortical
impact). In the current study, spillway force-induced brain injury in
salmon brain robustly produces SBDPs parallel to those produced by
their mammalian counterparts (Fig. 3, 4). When compared with the
visible injury observations 48 hours post passage, the trends in
passage impact correlate with the presence of SBDP120. In
particular, the abundance of SBDP120 shows increasing expression
with increasing visible injury. Predicted amino acid sequence
homology for the SBDP120 cleavage site, and binding of the specific
SBDP120 antibody provide strong evidence for conservation of
functional homology. Based on the known mammalian expression
pattern, the increase in expression is hypothesized to be evidence of
apoptotic breakdown of intact aII-spectrin, a likely event that would
occur following physical traumato brain tissues. The lack of complete
homology of mammalian SBDPs in salmon brain tissues may be
related more to the evidence of genome duplication in the salmonids
[29] and the loss of function due to redundancy [30], or adaptation
for different functions. Without a complete aII-spectrin sequence in
salmon, these remain assumptions.
Two different pathways that lead to brain cell death are depicted
in Figure6, showing how calpain and caspase proteases may break
down salmonid brain cellular proteins during both acute necrosis
and delayed apoptosis phases of salmon head injury, respectively.
Therefore, aII-spectrin was degraded by these two proteases,
producing SBDPs as possible spillway force-mediated salmon brain
injury biomarkers. Based on this study, there appears to be basal
levels of SBDPs expressed in salmon brain tissues (Fig. 3), which
may indicate a normal turnover of neuronal cells experienced
during juvenile growth. Indeed, Zupanc [31] reviews the capability
of teleost brain tissues to display continuous neurogenesis
postembryonically and into adulthood. Soutschek and Zupanc
[32,33] describe the neuronal turnover process as apoptotic
regulation, but increased apoptosis is also seen in response to injury
and removal of injured or affected cells [reviewed in 31]. Although
the difference in hydraulic force is orders of magnitude lower than
passage through the spillway structures, it is possible that the
bypassed fish used as a field control experienced some mild injury,
and mayaccount for the presence ofSBDPs.However, thehatchery
control fish used for the protease digests did not experience any
field-related hydraulic forces, and the presence of SBDPs in the
control fish lends support to the neurogenesis hypothesis. The
increase in SBDP120 appears to correlate with observations of head
injury and could be used as a potential biomarker forsubacute brain
damage induced by migration passage. These results have increased
significance following the recent Biological Opinion for the Federal
Columbia River Power System [34] for cooperating agencies to
develop configuration and operations plans that detail overall
survival improvements for in-river migrating fish.
Although currently there is no threshold head injury biomarker
expression level known that would indicate an outcome such as
recovery, impaired health, or delayed mortality, the results can be
compared among passage types to determine optimal passage
trajectories, and are an improvement over current assessments that
involve visible injury assessment for hundreds of fish per passage
type. Non-lethal sampling is a preferred alternative to sampling
brain tissue, and cerebral spinal fluid (CSF) is the biofluid used for
human biomarker analysis [5,6,8]. However, CSF is not a viable
alternative for juvenile fish that range in total size from 80–
140 mm. Blood samples (including serum or plasma) may be a
preferable biofluid for salmon brain injury biomarker monitoring.
We are working to get salmon specific antibodies to enable the
detection of the biomarker in blood. In addition, future work to
assess degree of injury in relation to specific outcomes are
underway and will include temporal studies under defined,
laboratory simulations to determine more specific biomarker
metrics for longer-term prognosis of fish outcome.
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